Omicron vs. Delta Infection: Contrasting Clinical Presentations and Epidemiological Features
A comparison of patients infected with Delta versus Omicron COVID-19 variants presenting to Paris emergency departments reveals contrasting clinical presentations and epidemiological features, shedding light on the evolving dynamics of the COVID-19 pandemic.
November 2022
Heart Complications Rare but Treatable After COVID-19 in Children and Young Adults
Heart complications following COVID-19 illness are rare but treatable in children and young adults, emphasizing the importance of post-acute care services and cardiac monitoring to detect and manage sequelae of COVID-19 infection.
November 2022
Antibodies Against SARS-CoV-2 in Human Milk: Implications for Infant Immunity
SARS-CoV-2-specific antibodies present in human milk may provide passive immunity to milk-fed infants for up to six months, offering potential protection against COVID-19 and highlighting the importance of breastfeeding in infant health and immunity.
November 2022
PAHO Urges Inclusion of COVID-19 Vaccine in Routine Vaccination Programs
The Pan American Health Organization (PAHO) emphasizes the importance of integrating the COVID-19 vaccine into routine vaccination systems to sustain immunization efforts and prevent resurgence of the virus amidst declining cases and easing restrictions.
November 2022
Cognitive Disorders One Year After COVID-19: Longitudinal Observations
Long-term cognitive impairment is common following SARS-CoV-2 infection, according to longitudinal observations, highlighting the need for comprehensive neurological assessment and management strategies to address post-COVID cognitive sequelae.
November 2022
Rising Incidence of Contact Dermatitis: Impact of COVID-19 Preventive Measures
There is real evidence of the increasing prevalence of allergic and irritant contact dermatitis associated with COVID-19 preventive measures, highlighting the need for proactive dermatological management and skin protection strategies in response to pandemic-related skin issues.
November 2022
Continuing COVID-19 Pandemic: Global Trends in New Infections
New infections of COVID-19 have increased by 8% worldwide compared to the previous week, with 11 million new cases reported, indicating ongoing transmission dynamics and the need for sustained public health interventions to control the pandemic.
November 2022
Post-COVID-19 Increased Risk of Deep Vein Thrombosis
Post-COVID-19 patients face an increased risk of deep vein thrombosis, highlighting the need for thromboprophylaxis measures and ongoing surveillance to prevent thrombotic complications in individuals recovering from COVID-19 infection.
November 2022
Coinfection of COVID-19 with Influenza and Other Viruses: Clinical Implications
Routine testing for influenza viruses is recommended for all patients hospitalized with COVID-19 to identify coinfection and guide appropriate management strategies, given the potential implications for disease severity and treatment outcomes.
November 2022
Identifying COVID-19 Patients at Risk of Mortality: Role of Prolonged QT Interval
Prolonged QT interval on the ECG is identified as an independent risk factor for both myocardial injury and 1-year mortality in patients with COVID-19, underscoring the prognostic significance of cardiac electrophysiological abnormalities in disease outcomes.
November 2022
